Prof Ricard Cervera, MD
Rheumatology — Hospital Clínic de Barcelona, Spain
Ricard Cervera
LeadR Profile
Rheumatology
Subspecialties: Immunology - Internal Medicine - Hematology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1988 - 2026
Number : 881
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Methodology of the development of the EULAR Antiphospholipid Syndrome Disease Activity Score (EAPSDAS). antiphospholipid syndrome, physicians, surveys and questionnaires | EULAR Rheumatol Open | 2025 | 1 |
| ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2). lupus erythematosus, systemic, therapeutics, erythema | Lancet Rheumatol | 2026 | 0 |
| Clinical characteristics of patients with primary antiphospholipid syndrome and "single" antiphospholipid antibody: Retrospective results from the APS ACTION clinical database and repository ("registry"). registries, antibodies, antiphospholipid, classification, lupus erythematosus, systemic, antiphospholipid syndrome, lupus coagulation inhibitor, thrombosis | Lupus | 2026 | 0 |
| Real-world treatment patterns and outcomes in moderate-to-severe SLE: findings from the Spanish SPOCS cohort. depression, quality of life, lupus erythematosus, systemic, therapeutics | Lupus Sci Med | 2026 | 1 |
| Skin involvement in the catastrophic antiphospholipid syndrome: A review from CAPS registry. registries, skin, mortality, livedo reticularis, lupus erythematosus, systemic, antiphospholipid syndrome, prevalence, necrosis, lupus coagulation inhibitor, antibodies, anticardiolipin | Lupus | 2026 | 0 |
Clinical Studies 7
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 14
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Modelling and Control of Non invasive Vagus Nerve Stimulation for Autoimmune Diseases (1A) NCT05704153 — vagus nerve stimulation, autonomic nervous system, autonomic nervous system diseases, primary dysautonomias, lupus erythematosus, systemic, parasympathetic nervous system, vagus nerve, autoimmune diseases, therapeutics, nervous system, nervous system diseases | N/A | Recruiting | 2022 |
LeadR Networks
Main global connection map